Viewing Study NCT04720092


Ignite Creation Date: 2025-12-24 @ 3:20 PM
Ignite Modification Date: 2025-12-25 @ 2:11 PM
Study NCT ID: NCT04720092
Status: COMPLETED
Last Update Posted: 2021-01-22
First Post: 2021-01-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial to Learn How a New Liquid Form of Rivaroxaban Behaves and How Safe it is Compared to the Current Tablet Form of Rivaroxaban in Healthy Male Participants
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module